The neuroAD system is based on Neuronix’s patent-pending Non Invasive Cortical Enhancer (NICE™) technology. This patent-pending technology combines two modalities concurrently:
- Focused Transcranial Magnetic Stimulation (TMS) to stimulate the targeted areas of the brain responsible for memory and learning. This stimulation induces LTP (Long-Term Potentiation), which is associated with learning and memory processes, and making these areas of the brain more receptive to Cognitive Training;
- Tailored Cognitive Training to target the areas of the brain responsible for memory and learning that are affected by Alzheimer’s Disease
The concurrent use of these two modalities has been shown to have a synergistic effect. By uniquely combining TMS and targeted Cognitive Training, memory restoration is “fixated” and becomes long lasting.
NeuroAD is an investigational device, currently not available in the USA